Back to results
US 2013/0296565 A1Published application
L-malate salts of 6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5h-pyrrolo[3,4-b]pyrazine
AssigneeSunovion Pharmaceuticals Inc.
InventorsH. Scott WILKINSON, Richard HSIA, Tushar MISRA, Kostas SARANTEAS, Patrick MOUSAW
Life of this patent
Estimating the term…
Abstract
A novel L-malate salt of (6-(5-chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine) is provided.
Claims2
-12. (canceled)
A method for decreasing the bitterness of an oral dosage form containing eszopiclone comprising providing said eszopiclone in the form of its L-malate salt.
Dependencies are inferred from the claim text.